TrkB variants, in general, have been shown to alter default recycling pathways33 and exhibit cross-talk with other tyrosine kinases in different cancer types44, suggesting that interactions with other signaling cascades have yet to be elucidated. This evidence concerns the gene NTRK2 and cancer.